A pharmacogenomic report raises a simple question: I had a gene test, so what does it mean?
A pharmacogenomic report can look like a verdict. It is not. Here is what it is, what a pharmacist reads in one and what it cannot tell you.
What pharmacogenomics is
Pharmacogenomics is the study of how a person’s genes can affect the way their body handles certain medications. Many of the genes involved carry the instructions for enzymes that break medications down, mostly in the liver. Others affect how a medication reaches the place in the body where it acts.
A pharmacogenomic test looks at specific variants in a specific set of genes. The result does not change over a person’s life. What changes is how much is known about each gene and each medication.
What a report actually says
Most reports have two layers. The first is the genotype: which variants the test found. The second is the interpretation, usually a label for how active an enzyme is expected to be. Labels such as poor, intermediate, normal and rapid metabolizer are common.
Many reports add a third layer: a list of medications, sorted into groups or colors, with a note about each. That list is the part people focus on. It is also the part that needs the most context.
What a pharmacist checks first
Which genes were tested. A panel covers only the genes on it. If a gene was not tested, the report says nothing about it, even when the medication list makes it look complete.
The full medication list. Other medications, including over-the-counter products and supplements, can slow down or speed up the same enzymes the test looks at. A person whose genes point one way can, in practice, handle a medication differently because of something else they take. A gene report read without the medication list is only half the picture.
The evidence behind each note. Some gene and medication pairs have peer-reviewed clinical guidelines behind them, from groups such as the Clinical Pharmacogenetics Implementation Consortium (CPIC). Others rest on far less. A report can present both in the same color.
The question the prescriber is asking. A report is most useful when it answers a specific question about a specific medication. That is the place to start, not the whole list.
What a gene report cannot tell you
It cannot tell you whether a medication will work for you. Genes are one factor among many. Age, kidney and liver function, other medications, other conditions and how a medication is taken all matter too.
It is not a list of medications to stop. A note on a report is information for the prescriber, not an instruction for the patient.
And it is not the final word. As research grows, guidance for a gene and medication pair can change. A report printed years ago may deserve a fresh read.
Who decides what
The prescriber decides the therapy. A pharmacogenomic result is one input into that decision, alongside everything else the prescriber knows about the patient.
The pharmacist’s part is to read the report carefully, put it next to the full medication list and point out to the prescriber what looks relevant, along with how solid the evidence behind it is. Then the prescriber decides.
Where it meets compounding
Pharmacogenomics and compounding come from the same idea: the individual patient matters. Both start with questions about one person rather than the average one.
They stay separate steps, though. A gene report does not write a formula, and a compounded preparation is never a substitute for the prescriber’s decision. How a new preparation is worked out is described in what formula development means in a compounding pharmacy.
What patients and clinic teams should know
Keep a copy of your report, and share it with every prescriber and every pharmacist you use, not just the one who ordered the test.
Do not stop or change a medication because of a report on your own. Take your questions to your prescriber, who decides the therapy, and ask your pharmacist to walk through the report with you.
If you are a journalist, prescriber or clinic leader with a question about pharmacogenomics or formula development, use the inquiry form. To learn more about ProCompounding Pharmacy, visit ProCompounding.
COMMON QUESTIONS
What is pharmacogenomics?
Pharmacogenomics is the study of how a person’s genes can affect the way their body handles certain medications. Many of the genes involved carry the instructions for enzymes that break medications down.
What does a pharmacist look at in a pharmacogenomic report?
Which genes were tested, the person’s full medication list including over-the-counter products and supplements, how solid the evidence behind each note is, and the specific question the prescriber is asking.
Can a gene test tell me which medication will work for me?
No. Genes are one factor among many, alongside age, kidney and liver function, other medications and other conditions. A report is information for the prescriber, who decides the therapy.
Should I change my medication after a pharmacogenomic test?
Not on your own. Share the report with your prescriber, who decides the therapy, and ask your pharmacist to walk through it with you.
General education—not individual medical advice. Treatment decisions remain with the prescriber.